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1. Introduction 
It is well-known that the movement of adenine nu- 
cleotides (AdN) across the inner mitochondrial mem- 
brane is markedly decreased both by unsaturated [l- 
41 and by saturated [4-61 long-chain fatty acids. A 
similar effect is displayed by palmityl-CoA as demon- 
strated recently with isolated mitochondria of rat heart 
[7] and rat liver [5,6,8-lo]. In fact, long chain 
acyl-CoA esters are much stronger inhibitors of mito- 
chondrial AdN translocation than the corresponding 
free fatty acids and carnitine esters [6]. Therefore, 
long-chain acyl-CoA compounds such as palmityl- 
CoA are the more likely candidates for the regula- 
tion of cell metabolism at the level of mitochondrial 
AdN transport. 
For a better appreciation of the possible physio- 
logical role of this inhibitory effect of palmityl-CoA, 
some of its metabolic implications in isolated rat-liver 
mitochondria were studied. In the present report the 
influence of small amounts of extramitochondrial 
palmityl-CoA on palmitate oxidation and concomi- 
tant ketogenesis is shown. Our results clearly indicate 
that the inhibition by palmityl-CoA of ADP uptake in 
the mitochondria is reflected in increased 3-hydroxy- 
butyrate/acetoacetate (HB/Acac) ratios and in prefer- 
ential conversion of acetyl-CoA (AcCoA) into ketone 
bodies. In a following publication [ 1 l] the stimula- 
tion of pyruvate carboxylation by added palmityl-CoA 
will be discussed. 
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2. Methods and materials 
Rat-liver mitochondria were isolated according to 
Myers and Slater [ 121 and washed once more in 
order to remove all endogenous carnitine. Treatment 
of mitochondria with Nagarse was performed essen- 
tially as described by Pande and Blanchaer [ 131. 
Total AcCoA generated during P-oxidation was cal- 
culated from the observed oxygen consumption and 
the accumulation of ketone bodies, acetylcarnitine 
and citrate. Full details of this calculation and its un- 
derlying assumptions are given elsewhere [ 14, 151. 
The acetyl-ratio is defined as that part of the total 
AcCoA that is converted into ketone bodies. 
Oxygen uptake was measured at 25” with a Gilson 
Respirometer. The standard reaction medium con- 
tained 50 mM sucrose, 5 mM MgCl,, 2 mM EDTA, 
15 mM KCl, 50 mM Tris-Cl pH 7.5,20 n&l potassium 
phosphate pH 7.5, 20 mM glucose, 2.6 U of hexokin- 
ase, 0.5 mM ADP and 0.5 mM L-malate. Malate was 
included in order to lower the control values of the 
acetyl-ratio. Reactions were started by addition of 
mitochondria. Final volume, 2.0 ml. After 16 min 
HCIO, was added and metabolites were assayed spec- 
trophotometrically in the deproteinized supernatants 
using standard enzymic methods. 
L-can-mine chloride was a generous gift of Otsuka 
Pharm. Fact. (Osaka). L-octanoylcarnitine and L-lino- 
leylcarnitine were kindly donated by Dr. J. Bremer 
and Dr. B.O. Christophersen (Oslo). Nagarse (subtil- 
opeptidase A) was obtained from Serva. Bovine serum 
albumin (BSA), fraction V, was defatted and dialyzed 
before use [ 161. Hexokinase was also dialyzed and 
its activity (U) after dialysis was measured as glucose- 
6-phosphate production @moles/min) at 25” in the 
above-mentioned standard medium, ADP being re- 
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Table 1 
Influence of acyl-CoA esters on palmitate oxidation. 
October 1972 
Additions A0 A AcCoA Acetyl- HB/Acac 
(patoms) @moles) ratio ratio 
None 10.34 2.19 0.15 0.23 
Palmityl-CoA 4.04 2.18 0.82 2.56 
Octanoyl-CoA 10.01 2.16 0.17 0.20 
CoASH 4.66 1.54 0.49 1.53 
Atractylate 4.51 1.87 0.59 1.29 
Palmityl-CoA + BSA 11.47 2.64 0.20 0.30 
The standard reaction medium (see Methods) was supplemented with 0.5 mM palmitate. Further additions: palmityl-CoA (3.1 
mnoles/mg protein), octanoyl-CoA (2.6 nmoles/mg protein), 0.1 mM CoASH, 4.5 pg atractylate, 15 mg BSA. Mitochondrial pro- 
tein, 10.2 mg. 
placed by 5 mM ATP. Other biochemicals and experi- 
mental details were as previously described [6]. 
3. Results and discussion 
The presence of exogenous palmityl-CoA during 
palmitate oxidation increased the HB/Acac ratio and 
acetyl-ratio far beyond their control values, as shown 
in table 1 (lines 1 and 2). A half-maximal stimulation 
of the acetyl-ratio was observed at a concentration of 
palmityl-CoA of about 5 nmoles/mg protein (table 
2). In view of the inhibition of mitochondrial AdN 
translocation by long-chain acyl-CoA esters [ 5-101 
these observations can be explained as follows. Due 
to the interference of palmityl-CoA with ADP uptake, 
the intramitochondrial phosphate potential is in- 
creased. This in turn causes a higher reduction level 
of the mitochondrial nicotinamide nucleotides [17] 
which is reflected in the increased HB/Acac ratio [ 181 
At elevated NADH/NAD+ ratios, the intramitochon- 
drial level of oxaloacetate is lowered. As a conse- 
quence [ 14, 15,19-21; cf. 221, citrate synthesis 
will decrease and AcCoA is preferentially diverted 
towards ketone body formation. Control experiments 
(not shown) confirmed that the palmityl-CoA effect 
was not due to an inhibition of hexokinase activity 
by palmityl-CoA. 
Table 1 further shows: i) a negligible effect of 
octanoyl-CoA, in keeping with the observed lack of 
inhibition of ADP uptake by this compound [6] ; 
ii) a suppression of the palmityl-CoA effect by excess 
BSA, and iii) pronounced effects of atractylate and 
CoASH, similar to that of palmityl-CoA. 
Table 2 
Palmitate oxidation at various concentrations of added palmityl-CoA. 
Palmityl-CoA A0 A AcCoA Acetyl- HB/Acac 
concentration batoms) (pmoles) ratio ratio 
(nmoles/mg) 
0 12.79 3.09 0.21 0.23 
0.54 12.09 2.96 0.25 0.24 
1.08 11.90 2.92 0.26 0.27 
1.62 11.86 2.96 0.28 0.28 
2.16 11.47 2.86 0.29 0.32 
3.24 10.89 2.89 0.36 0.47 
5.40 9.45 2.85 0.48 0.85 
10.80 6.11 2.52 0.69 1.94 
16.20 5.33 2.43 0.74 2.24 
The standard reaction medium was supplemented with 0.5 mM palmitate and various concentrations of palmityl-CoA. Mitochon- 
drial protein, 9.2 mg. 
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Fig. 1. Rate of palmitate oxidation as a function of hexoki- 
nase concentration. To the standard reaction medium 0.4 mM 
palmitate (complexed with BSA in a molar ratio of 5: 1) and 
varying amounts of hexokinase were added. Mitochondrial 
protein, 9.3 mg. No further additions; (o-o-o); with 25 
nM CoASH, 0.25 mM glutathione and 0.5 mM L-carnitine: 
(-). 
The effect of added CoASH was already discussed 
earlier [6] : In ATPase experiments it was observed 
that in the presence of Mg2+; ATP, palmitate and 
CoASH the“external” palmityl-CoA synthetase [23] 
builds up inhibitory levels of extramitochondrial 
palmityl-CoA, provided carnitine is absent. Obviously, 
this external activation can proceed equally well in 
oxidation experiments in the presence of hexokinase 
[cf. 241. The data shown in fig. 1 substantiate this 
conclusion. In the presence of carnitine and CoASH, 
the oxidation of pahnitate is mediated mainly by ex- 
ternal activation 1231. Fig. 1 shows that moderate con- 
centrations of hexokinase enhance the AcCoA flux 
by release of respiratory control, whereas the AcCoA 
flux gradually slows down at higher hexokinase levels. 
For comparison, the oxidation of palmitate in a 
medium without added CoASH and carnitine permit- 
ting only intramitochondrial pahnitate activation is 
also shown. 
As the results of fig. 1 predict, the effects of added 
CoASH on palmitate oxidation are partially counter- 
acted by an excessive amount of hexokinase (table 3, 
exp. 1). L-carnitine, lowering the concentration of 
external palmityl-CoA by the formation of L-palmi- 
tylcarnitine, is more effective in reversing the effects 
of added CoASH: Virtually no effect of CoASH is 
observed (table 3, exp. 2) with mitochondria in 
which the palmityl-CoA synthetase localized in the 
outer mitochondrial membrane is destroyed by pre- 
incubation with Nagarse [ 13,24,25]. The effect of 
addition of r;-actylate shows that the inner membrane 
of the mitochondria is intact after Nagarse treatment. 
In short, if rat-liver mitochondria are allowed to 
oxidize palmitate (mediated by internal activation) 
in the presence of CoASH, a concomitant synthesis 
Table 3 











1 None 13.27 3.23 0.27 0.19 
CoASH 4.69 2.23 0.74 2.42 
CoASH + hexokinase 7.25 3.05 0.70 1.28 
CoASH + Cn (0.1 mM) 5.82 2.85 0.71 2.37 
CoASH + Cn (0.5 mM) 8.75 3.66 0.57 1.14 
CoASH + Cn (1.0 mM) 10.35 3.76 0.48 0.72 
CoASH + Cn (2.0 mM) 11.51 3.75 0.41 0.51 
2 None 5.51 1.24 0.13 <O.Ol 
CoASH 6.12 1.37 0.13 0.13 
Atractylate 2.19 1.09 0.66 1.57 
To the standard reaction medium 0.5 mM palmitate was added. Further additions: 0.1 mM CoASH, 13 U of hexokinase, varying 
amounts of L-carnitine (Cn) and 4.5 ng atractylate. Mitochondrial protein, 8.4 mg (exp. 1) and 9.7 mg (exp. 2). In exp. 1 normal 
mitochondria were used; in exp. 2 the mitochondria were pretreated with Nagarse (9.1 ng/mg mitochondrial protein). 
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Table 4 











1 None 7.07 (10.69) 2.39 (2.93) 0.54 (0.38) 0.38 (0.08) 
CoASH (2 PM) 6.52 (10.27) 2.41 (2.91) 0.61 (0.41) 0.46 (0.07) 
CoASH (5 /.IM) 5.29 (10.53) 2.28 (2.96) 0.69 (0.40) 0.61 (0.07) 
CoASH (10 PM) 3.76 (10.76) 1.77 (3.05) 0.73 (0.41) 2.25 (0.11) 
CoASH (20 PM) 3.92 (10.50) 1.61 (3.02) 0.67 (0.44) 3.91 (0.16) 
CoASH (40 PM) 3.26 (4.66) 1.48 (2.31) 0.73 (0.76) 4.40 (1.05) 
CoASH (80 PM) 3.79 (3.16) 1.66 (1.54) 0.72 (0.74) 2.75 (8.50) 
None 6.46 2.34 0.63 0.19 
CoASH 3.31 1.73 0.86 1.24 
CCCP 6.07 2.16 0.62 0.12 
CoASH+CCCP 5.23 1.96 0.66 0.12 
BSA 6.95 2.43 0.60 0.09 
CoASH + BSA 6.39 2.04 0.52 0.08 
Exp. 1: The standard reaction medium was supplemented with 0.275 mM L-palmitylcarnitine and varying concentrations of 
CoASH. Values in brackets represent incubations with 0.5 mM L-carnitine. Mitochondrial protein, 6.9 mg. Exp. 2: To the stan- 
dard reaction medium 0.18 mM L-palmitylcarnitine was added. Further additions: 100 MM CoASH, 0.9 PM carbonylcyanide 
m-chlorophenylhydrazone (CCCP) and 10 mg BSA. Mitochondrial protein, 5.4 mg. 
and accumulation of external palmityl-CoA occurs respect to AdN; it is readily reversible with BSA and 
leading to marked increases in HB/Acac ratios and it is observed at relatively low non-detergent concen- 
acetyl-ratios. trations of palmityl-CoA [6, 7,9, lo]. 
Analogous conclusions may be drawn from the 
effect of CoASH on L-palmitylcarnitine oxidation 
(table 4, exp. 1). In this case palmityl-CoA syn- 
thesis is effected by the carnitine palmityltrans- 
ferase reaction [26]. At low CoASH concentrations 
addition of 0.5 mM L-carnitine can protect against 
the effect of CoASH. From the observation that 
the uncoupler CCCP abolishes the effect of added 
CoASH (table 4, exp. 2), it may be concluded that 
the shifts in HB/Acac ratio and acetyl-ratio caused 
by the addition of CoASH are really due to the 
induced respiratory control. 
With some enzymes, the inhibition by palmityl- 
CoA is reversed by palmitylcarnitine when both 
agents are present at comparable concentrations [28, 
331. However, the data reported in table 4 show that 
this is not the case with the AdN translocator. More- 
over, in other experiments (not shown) the inhibition 
of the DNP-induced ATPase activity by a suboptimal 
amount of palmityl-CoA was enhanced by addition 
of palmitylcarnitine, linoleylcarnitine, palmitate or 
linoleate, whereas octanoylcarnitine had no effect [cf. 
61. 
The question whether or not inhibition of mito- 
chondrial AdN transport by palmityl-CoA plays 
a role in vko still remains open. An overwhelming 
number of enzymes have been reported to be inhi- 
bited by palmityl-CoA [e.g., 27-321. The diversity 
of these enzymes and the almost complete irrever- 
sibility of the inhibition which is observed in many 
cases have aroused serious doubts as to the physio- 
logical significance of these inhibitory effects [30- 
321. On the other hand, the inhibition of AdN 
translocation by pahnityl-CoA is competitke with 
The observation that BSA can reverse the inhibi- 
tion by palmityl-CoA in vitro shows that the pos- 
sible binding of palmityl-CoA to intracellular proteins 
could prevent palmityl-CoA effects Jn uivo. This pos- 
sibility cannot be excluded completely at the mo- 
ment. Hepatic levels of long-chain acyl-CoA are ele- 
vated to about 130 nmoles/g wet wt in starvation 
[27, 341. Assuming the protein content of rat liver to 
be 165 mg/g wet wt [cf. 351, and the intracellular 
distribution of long-chain acyl-CoA to be homogene- 
ous, one arrives at a long-chain acyl-CoA concentra- 
tion of 0.8 nmole per mg protein. This value exceeds 
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the Ki of the AdN translocator for palmityl-CoA with 
respect to ADP (0.5 nmole/mg protein) calculated 
for isolated mitochondria in our preceding paper [6]. 
It should be noted, however, that differences in the 
binding affinities of the various proteins, competition 
of fatty acids and fatty acyl-esters for the same bind- 
ing sites as well as compartmentation may introduce 
errors in the above calculation. For instance, a rela- 
tively large part of the total long-chain acyl-CoA 
could well be present in the mitochondrial matrix 
since rat-liver contains 60 mg mitochondrial protein/g 
wet wt [36] and 2 nmoles intramitochondrial 
CoASH/mg mitochondrial protein [37]. As yet it is 
not known whether intramitochondrial long-chain 
acyl-CoA contributes to the inhibition of AdN trans- 
location. 
The increased HB/Acac ratios and the enhanced 
ketogenesis, observed in our in vitro incubations upon 
addition of palmityl-CoA, are found in vivo in most 
metabolic states with a rapid rate of fatty-acid oxida- 
tion [ 18,20,34]. In this connection it is interesting 
to note that McLean et al. [34], comparing different 
metabolic states, concluded that only in the liver of 
the starved rat the mitochondrial phosphate potential 
is increased. On the other hand, the cytoplasmic phos- 
phate potential is lowered in starvation [38]. It may 
well be that the phosphate potentials of mitochondria 
and cytoplasm are out of equilibrium as a conse- 
quence of the inhibition of the AdN translocator by 
long-chain acyl-CoA, since the level of the latter is 
known to be elevated in starvation [27, 341. 
In conclusion, long-chain acyl-CoA compounds, 
modifying the rate of AdN transport across the mito- 
chondrial inner membrane, may play a role in the 
regulation of ketogenesis in vivo, especially in starva- 
tion and in starvation followed by refeeding fat. 
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